arrow
K

Kazuaki Taguchi

Hiroshima University
H指数:30
被引数:3,140

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Ampicillin/ceftriaxone vs. β-lactam/aminoglycoside combination therapy for Enterococcus faecalis infective endocarditis: a systematic review and meta-analysis

氨苄西林/头孢曲松与β-内酰胺/氨基糖苷类联合疗法治疗粪肠球菌感染性心内膜炎:一项系统评价和荟萃分析

2026-08-120
PRE
Age and body weight-adjusted infusion rate (mg/kg/h) as risk factors for vancomycin infusion reaction in patients receiving perioperative antimicrobial prophylaxis: a retrospective cohort study

年龄和体重调整后的输注速率(mg/kg/h)作为接受围手术期抗菌药物预防的患者发生万古霉素输注反应的危险因素:一项回顾性队列研究

2026-05-190
OA
Application of epithelial lining fluid drug concentrations to MICi-Based PK/ PD modeling of cefepime/nacubactam in a murine model of CPE pneumonia

上皮衬液药物浓度在cefepime/nacubactam针对CPE肺炎小鼠模型的MICi-Based PK/PD建模中的应用

2025-12-010
PRE
Efficacy and safety of isavuconazole for invasive fungal infections: A systematic review and meta-analysis of randomized controlled trials

伊曲康唑的疗效和安全性:用于侵袭性真菌感染的系统评价和随机对照试验的Meta分析

2025-10-010
OAAI
Risk stratification of AUC upward deviation in patients with low serum creatinine levels treated with vancomycin: a multicenter retrospective study

万古霉素治疗低血清肌酐水平患者AUC向上偏离的风险分层:一项多中心回顾性研究

2025-06-010
PRE
Reply to Mitsuboshi, Enhancing result reliability by addressing potential confounding factors

回复Mitsuboshi,通过解决潜在的混杂因素来提高结果的可靠性

2025-02-060
OAAI
Treatment success prediction in patients with methicillin-resistant coagulase-negative staphylococci infections, using vancomycin AUC24/MIC ratio: a multicentre retrospective cohort study
2024-12-170
PRE
Identification of Patients Who Require Two-Point Blood Sampling for the Peak and Trough Values Rather Than One-Point Blood Sampling for the Trough Value for the Evaluation of AUC of Vancomycin Using Bayesian Estimation
2024-10-212
PRE
Carbon monoxide-loaded cell therapy as an exercise mimetic for sarcopenia treatment

一氧化碳负载的细胞疗法作为肌肉减少症治疗的运动模拟物

2024-08-011
PRE